Abstract
The purpose of this study was to describe the results of Nd:YAG laser application in hereditary hemorrhagic telangiectasia (HHT) patients and to measure the Health-Related Quality of Life (HR-QoL) in patients with HHT before and after Nd:YAG laser application in a prospective, clinical trial at a university hospital. Twenty-seven consecutive patients with HHT and mild to moderate degrees of epistaxis were followed-up for 2 years after Nd:YAG laser treatments. Recurrence of epistaxis after Nd:YAG laser application and measurement of HR-QoL using the International Quality of Life Assessment questionnaire, version 1.1 (IQOLA 1.1), was found. Eight patients (30%) received only one Nd:YAG laser treatment, 15 (56%) had a recurrence and received a second treatment and 4 (14%) had two recurrences and received three Nd:YAG laser treatments. HR-QoL was improved 2 years after the first Nd:YAG laser application in both its Physical Health Dimension (47.5±2.9 vs. 38.1±2.3 before treatment, P <0.05) and Mental Health Dimension (45.1±2.7 vs. 39.6±2.4 before treatment, P <0.05). Although no curative treatment for HHT exists, Nd:YAG laser treatment seems to constitute a simple and efficient method of epistaxis control, resulting in a significant improvement in quality of life.
Similar content being viewed by others
References
Rendu M (1896) Epistaxis repetees chez un sujet porteur de petits angiomescutanes et mugueux. Bull Mem Soc Med Hop Paris 13:731–733
Osler W (1901) On a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucous membranes. Johns Hopkins Hops Bull 12:333–337
Mei-Zahav M (2003) Osler-Weber-Rendu: a life-threatening disease in adults and children. Harefuah 142:852–856
Marchuk D (1998) Genetic abnormalities in hereditary hemorrhagic telangiectasia. Curr Opin Hematol 5:332–338
Shah R, Dhingra J, Shapshay S (2002) Hereditary hemorrhagic telangiectasia: a review of 76 cases. Laryngoscope 112:767–773
Haitjema T, Westermann C, Overtoom T, Timmer R, Disch F, Mauser H, Lammers J (1996) Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): new insights in pathogenesis, complications, and treatment. Arch Intern Med 156:714–719
Werner JA, Lippert BM, Geisthoff UW, Rudert H (1997) Nd:YAG laser therapy of recurrent epistaxis in hereditary hemorrhagic telangiectasia. Laryngorhinootologie 76:495–501
Shovlin C, Guttmacher A, Buscarini E, Faughnan M, Hyland R, Westermann C, Kjeldsen A, Plauchu H (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91:66–67
Byahatti S, Rebeiz E, Shapshay S (1997) Hereditary hemorrhagic telangiectasia: what the otolaryngologist should know. Am J Rhinol 11:55–62
Lund V, Howard D (1999) A treatment algorithm for the management of epistaxis in hereditary hemorrhagic telangiectasia. Am J Rhinol 13:319–322
Weissman J, Jungreis C, Johnson J (1995) Therapeutic embolization for control of epistaxis in a patient with hereditary hemorrhagic telangiectasia. Am J Otolaryngol 16:138–140
Pizzi G, Turcato G, Polico R, Busetto M, Antonello M, Princivalli M (1995) Brachytherapy of epistaxis in Rendu-Osler disease. Indications, technic, results. Radiol Med (Torino) 89:861–864
Rebeiz E, Bryan D, Ehrlichman R, Shapshay S (1995) Surgical management of life-threatening epistaxis in Osler-Weber-Rendu disease. Ann Plast Surg 35:208–213
Lennox P, Harries M, Lund V, Howard D (1997) A retrospective study of the role of the argon laser in the management of epistaxis secondary to hereditary haemorrhagic telangiectasia. J Laryngol Otol 111:34–37
Ducic Y, Brownrigg P, Laughlin S (1995) Treatment of haemorrhagic telangiectasia with the flashlamp-pulsed dye laser. J Otolaryngol 24:299–302
Vickery C, Kuhn F (1996) Using the KTP/532 laser to control epistaxis in patients with hereditary hemorrhagic telangiectasia. South Med J 89:78–80
Kardos T, Holt T, Ferguson M (1989) Histological evaluation of the effect of a miniature carbon dioxide laser on oral mucosa. Int J Oral Maxillofac Surg 18:117–120
Shapshay S, Rebeiz E, Bohigian R, Hybels R (1990) Benign lesions of the larynx: should the laser be used? Laryngoscope 100:953–957
Bergler W, Gotte K, Riedel F, Back W, Hormann K (1998) Argon plasma coagulation in treatment of hereditary telangiectasia of the nasal mucosa. HNO 46:228–232
Bergler W, Sadick H, Gotte K, Riedel F, Hormann K (2002) Topical estrogens combined with argon plasma coagulation in the management of epistaxis in hereditary hemorrhagic telangiectasia. Ann Otol Rhinol Laryngol 111:222–228
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karapantzos, I., Tsimpiris, N., Goulis, D.G. et al. Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire. Eur Arch Otorhinolaryngol 262, 830–833 (2005). https://doi.org/10.1007/s00405-004-0911-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-004-0911-0